Ritu Goila-Gaur

2.0k total citations
18 papers, 1.6k citations indexed

About

Ritu Goila-Gaur is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Ritu Goila-Gaur has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 15 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Ritu Goila-Gaur's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers) and Immune Cell Function and Interaction (7 papers). Ritu Goila-Gaur is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (15 papers) and Immune Cell Function and Interaction (7 papers). Ritu Goila-Gaur collaborates with scholars based in United States. Ritu Goila-Gaur's co-authors include Klaus Strebel, Eri Miyagi, Sandra Kao, Mohammad A. Khan, Sandrine Opi, Hiroaki Takeuchi, Eric O. Freed, Jan M. Orenstein, Karl Salzwedel and Carl Wild and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Virology.

In The Last Decade

Ritu Goila-Gaur

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ritu Goila-Gaur United States 16 1.3k 868 575 494 384 18 1.6k
Bärbel Schröfelbauer United States 10 1.2k 1.0× 665 0.8× 628 1.1× 589 1.2× 614 1.6× 11 1.8k
Thierry Huet France 13 713 0.6× 482 0.6× 423 0.7× 296 0.6× 203 0.5× 18 1.2k
Thomas Fricke United States 14 1.0k 0.8× 663 0.8× 627 1.1× 255 0.5× 240 0.6× 23 1.3k
Prakash Sista United States 18 807 0.6× 795 0.9× 507 0.9× 162 0.3× 359 0.9× 29 1.6k
Hendrik Huthoff Netherlands 19 918 0.7× 439 0.5× 882 1.5× 248 0.5× 251 0.7× 23 1.4k
Blake Wood United States 8 1.3k 1.0× 521 0.6× 322 0.6× 242 0.5× 773 2.0× 11 1.4k
Julie N. Reitter United States 15 635 0.5× 341 0.4× 374 0.7× 403 0.8× 325 0.8× 24 1.1k
H G Huisman Netherlands 7 1.5k 1.2× 945 1.1× 222 0.4× 253 0.5× 592 1.5× 8 1.6k
William J. Bosche United States 14 907 0.7× 567 0.7× 610 1.1× 217 0.4× 160 0.4× 16 1.2k
George M. Shaw United States 5 1.1k 0.8× 673 0.8× 334 0.6× 287 0.6× 602 1.6× 6 1.5k

Countries citing papers authored by Ritu Goila-Gaur

Since Specialization
Citations

This map shows the geographic impact of Ritu Goila-Gaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Goila-Gaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Goila-Gaur more than expected).

Fields of papers citing papers by Ritu Goila-Gaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritu Goila-Gaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Goila-Gaur. The network helps show where Ritu Goila-Gaur may publish in the future.

Co-authorship network of co-authors of Ritu Goila-Gaur

This figure shows the co-authorship network connecting the top 25 collaborators of Ritu Goila-Gaur. A scholar is included among the top collaborators of Ritu Goila-Gaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritu Goila-Gaur. Ritu Goila-Gaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Walker, Robert, Mohammad A. Khan, Sandra Kao, et al.. (2010). Identification of Dominant Negative Human Immunodeficiency Virus Type 1 Vif Mutants That Interfere with the Functional Inactivation of APOBEC3G by Virus-Encoded Vif. Journal of Virology. 84(10). 5201–5211. 29 indexed citations
2.
Miyagi, Eri, Charles R. Brown, Sandrine Opi, et al.. (2010). Stably Expressed APOBEC3F Has Negligible Antiviral Activity. Journal of Virology. 84(21). 11067–11075. 40 indexed citations
3.
Khan, Mohammad A., Ritu Goila-Gaur, Sandra Kao, et al.. (2009). Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization. Retrovirology. 6(1). 99–99. 21 indexed citations
4.
Goila-Gaur, Ritu, Mohammad A. Khan, Eri Miyagi, & Klaus Strebel. (2008). Differential Sensitivity of “Old” versus “New” APOBEC3G to Human Immunodeficiency Virus Type 1 Vif. Journal of Virology. 83(2). 1156–1160. 15 indexed citations
5.
Goila-Gaur, Ritu & Klaus Strebel. (2008). HIV-1 Vif, APOBEC, and Intrinsic Immunity. Retrovirology. 5(1). 51–51. 269 indexed citations
6.
Miyagi, Eri, Sandrine Opi, Hiroaki Takeuchi, et al.. (2007). Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1. Journal of Virology. 81(24). 13346–13353. 129 indexed citations
7.
Goila-Gaur, Ritu, Mohammad A. Khan, Eri Miyagi, Sandra Kao, & Klaus Strebel. (2007). Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity. Retrovirology. 4(1). 61–61. 61 indexed citations
8.
Goila-Gaur, Ritu, Mohammad A. Khan, Eri Miyagi, et al.. (2007). HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes. Virology. 372(1). 136–146. 38 indexed citations
9.
Kao, Sandra, Ritu Goila-Gaur, Eri Miyagi, et al.. (2007). Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif. Virology. 369(2). 329–339. 31 indexed citations
10.
Khan, Mohammad A., Ritu Goila-Gaur, Sandrine Opi, et al.. (2007). Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions. Retrovirology. 4(1). 48–48. 66 indexed citations
11.
Opi, Sandrine, Sandra Kao, Ritu Goila-Gaur, et al.. (2007). Human Immunodeficiency Virus Type 1 Vif Inhibits Packaging and Antiviral Activity of a Degradation-Resistant APOBEC3G Variant. Journal of Virology. 81(15). 8236–8246. 78 indexed citations
12.
Takeuchi, Hiroaki, Alicia Buckler‐White, Ritu Goila-Gaur, et al.. (2007). Vif Counteracts a Cyclophilin A-Imposed Inhibition of Simian Immunodeficiency Viruses in Human Cells. Journal of Virology. 81(15). 8080–8090. 15 indexed citations
13.
Adamson, Catherine S., Sherimay D. Ablan, Ritu Goila-Gaur, et al.. (2006). In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat). Journal of Virology. 80(22). 10957–10971. 98 indexed citations
14.
Opi, Sandrine, Hiroaki Takeuchi, Sandra Kao, et al.. (2006). Monomeric APOBEC3G Is Catalytically Active and Has Antiviral Activity. Journal of Virology. 80(10). 4673–4682. 62 indexed citations
15.
Khan, Mohammad A., Sandra Kao, Eri Miyagi, et al.. (2005). Viral RNA Is Required for the Association of APOBEC3G with Human Immunodeficiency Virus Type 1 Nucleoprotein Complexes. Journal of Virology. 79(9). 5870–5874. 148 indexed citations
16.
Kao, Sandra, Eri Miyagi, Mohammad A. Khan, et al.. (2004). Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells. Retrovirology. 1(1). 27–27. 86 indexed citations
17.
Goila-Gaur, Ritu, Dimiter Demirov, Jan M. Orenstein, Akira Ono, & Eric O. Freed. (2003). Defects in Human Immunodeficiency Virus Budding and Endosomal Sorting Induced by TSG101 Overexpression. Journal of Virology. 77(11). 6507–6519. 87 indexed citations
18.
Li, Feng, Ritu Goila-Gaur, Karl Salzwedel, et al.. (2003). PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proceedings of the National Academy of Sciences. 100(23). 13555–13560. 335 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bärbel Schröfelbauer Breakdown of academic impact, for papers by Thierry Huet Breakdown of academic impact, for papers by Thomas Fricke Breakdown of academic impact, for papers by Prakash Sista Breakdown of academic impact, for papers by Hendrik Huthoff Breakdown of academic impact, for papers by Blake Wood Breakdown of academic impact, for papers by Julie N. Reitter Breakdown of academic impact, for papers by H G Huisman Breakdown of academic impact, for papers by William J. Bosche Breakdown of academic impact, for papers by George M. Shaw
Rankless by CCL
2026